Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function

Nonsustained ventricular tachycardia, although usually asymptomatic, is associated with a high risk of sudden cardiac death in patients with depressed left ventricular function. To test the vulnerability of such patients to symptomatic and potentially life-threatening arrhythmias, complete electrophysiologic studies were performed in 58 patients with clinically documented nonsustained ventricular tachycardia (greater than or equal to three complexes but less than 15 seconds of self-terminating ventricular tachycardia by 24 hour ambulatory electrocardiographic [Holter] or telemetric monitoring) and abnormal left ventricular function (ejection fraction less than 50% by radionuclide angiography). All patients had nonsustained ventricular tachycardia in the absence of antiarrhythmic drugs, acute ischemia, long QT syndrome, recent infarction or electrolyte abnormalities. The stimulation protocol for each patient included the introduction of single, double and triple ventricular extrastimuli at three cycle lengths (sinus, 600 and 450 ms) and two right ventricular sites (apex and outflow tract). A sustained ventricular tachyarrhythmia was induced in 23 patients (40%) and a nonsustained ventricular tachycardia in 14 patients (24%). Induction of sustained tachycardia correlated with the presence of akinesia or aneurysm, or both, by radionuclide angiography, but not with ejection fraction or presence or absence of coronary artery disease. These results indicate that: 1) patients with clinical nonsustained ventricular tachycardia and chronic left ventricular dysfunction have a high incidence of inducible sustained ventricular tachycardia or ventricular fibrillation; and 2) electrophysiologic testing may allow further substratification of risk of sudden cardiac death in high risk patients with nonsustained ventricular tachycardia.     

Myocardial oxygen supply/demand ratio in aortic stenosis: hemodynamic and echocardiographic evaluation of patients with and without angina pectoris

Angina pectoris is a common symptom in patients with aortic stenosis without coronary artery disease. To investigate the correlates of angina pectoris, echocardiographic and hemodynamic data from 44 patients with aortic stenosis and no coronary artery disease (mean age 56 +/- 10 years) were analyzed. Twenty-three patients had no angina pectoris and 21 patients had angina pectoris. The ratio of the diastolic pressure-time index (area between the aortic and left ventricular pressure curves during diastole) to the systolic pressure-time index (area under the left ventricular pressure curve during systole), an index of the oxygen supply/demand ratio, was not different in patients with or without angina pectoris. There were no differences between patients with and without angina pectoris in echocardiographically determined wall thickness, chamber size, systolic and diastolic wall stress and left ventricular mass; in electrocardiographically defined voltage; and in hemodynamically defined aortic valve area, transaortic gradient and stroke work index. Thus, echocardiographic and hemodynamic measurements at rest are not significantly different in the presence or absence of angina pectoris in patients with aortic stenosis. Dynamic data appear to be essential for evaluation of the mechanisms of angina pectoris in patients with aortic stenosis.     

Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy

To determine whether failure of procainamide to prevent initiation of ventricular tachyarrhythmias during electrophysiologic testing predicted failure of other antiarrhythmic regimens, 81 consecutive patients with coronary artery disease whose ventricular tachyarrhythmias remained inducible during procainamide administration were studied. Overall, 26 (12%) of 216 subsequent drug studies were successful and at least one effective drug regimen was identified in 22 (27%) of the 81 patients. Drug success was significantly related to the arrhythmia induced at baseline study; 7% of drug studies were successful in patients with sustained ventricular tachycardia, 24% in patients with ventricular fibrillation, and 29% in patients with nonsustained ventricular tachycardia. An effective drug regimen was found in 11 (19%) of 59 patients with sustained ventricular tachycardia, 4 (50%) of 8 patients with ventricular fibrillation and 7 (50%) of 14 patients with nonsustained ventricular tachycardia. In patients with sustained ventricular tachycardia, failure of procainamide to suppress the arrhythmia correlated with failure of other agents used singly but not in combination. This study supports the view that when procainamide fails to prevent initiation of the arrhythmia in patients with inducible sustained ventricular tachycardia it is unlikely that other individual standard agents will be effective. However, combination regimens may suppress the arrhythmia and should be evaluated. In patients with nonsustained ventricular tachycardia, all agents should be evaluated because failure to respond to procainamide does not predict subsequent responses to other agents either alone or in combination.     

Natural history of the flail mitral leaflet syndrome: a serial 2-dimensional echocardiographic study

The syndrome of a flail mitral leaflet results in acute mitral regurgitation (MR). Twenty-nine patients with a flail mitral leaflet had serial 2-dimensional echocardiographic (2-D echo) examinations. Left ventricular (LV) and left atrial (LA) volumes and ejection fraction (EF) were obtained using a computerized light-pen system. Fifteen patients with the 2-D echo criteria of a flail mitral leaflet were treated medically and followed for a mean of 19 months. Eleven patients did not undergo surgery (Group IA). Four patients initially were treated medically, but ultimately required surgery (Group IB). On initial examination there was no difference in volumes and EF between these 2 groups. On follow-up, Group IA patients remained in New York Heart Association class I or II. The LV end-diastolic volume increased in the Group IA patients from 164 ± 27 to 203 ± 54 ml (p <0.01); LV ejection fraction tended to increase (from 51 ± 5 to 56 ± 8, p <0.06). On follow-up, Group IB patients had larger LA and LV volumes than Group IA patients.Fourteen patients were initially treated surgically (Group II). All but 1 were in New York Heart Association Class III or IV. On Initial examination LVEF was lower than in Group IA patients (51 ± 5 versus 43 ± 7, p = 0.05), but there was no difference in LV or LA volumes. On follow-up, a mean of 19 months after surgery, LVEF and LA volumes decreased.We conclude that a subset of patients with a flail mitral leaflet may be followed clinically without deterioration in LV function. Initial LVEF and hemodynamics are reasonably normal. Because increasing LV and LA volumes and changing clinical status are not a function of time, frequent 2-D echo and clinical evaluations are warranted in these patients. After mitral valve replacement, LVEF decreases without a significant change in LV volume.     

Left ventricular function in chronic aortic regurgitation

Left ventricular performance was determined in 42 patients with moderate or severe aortic regurgitation during upright exercise by measuring left ventricular ejection fraction and volume with radionuclide ventriculography. Classification of the patients according to exercise tolerance showed that patients with normal exercise tolerance (greater than or equal to 7.0 minutes) had a significantly higher ejection fraction at rest (probability [p] = 0.02) and during exercise (p = 0.0002), higher cardiac index at exercise (p = 0.0008) and lower exercise end-systolic volume (p = 0.01) than did patients with limited exercise tolerance. Similar significant differences were noted in younger patients compared with older patients in ejection fraction at rest and exercise (both p = 0.001) and cardiac index at rest (p = 0.03) and exercise (p = 0.0005). The end-diastolic volume decreased during exercise in 60% of the patients. The patients with a decrease in volume were significantly younger and had better exercise tolerance and a larger end-diastolic volume at rest than did patients who showed an increase in volume. The mean corrected left ventricular end-diastolic radius/wall thickness ratio was significantly greater in patients with abnormal than in those with normal exercise reserve (mean +/- standard deviation 476 +/- 146 versus 377 +/- 92 mm Hg, p less than 0.05). Thus, in patients with chronic aortic regurgitation: 1) left ventricular systolic function during exercise was related to age, exercise tolerance and corrected left ventricular end-diastolic radius/wall thickness ratio, and 2) the end-diastolic volume decreased during exercise, especially in younger patients and patients with normal exercise tolerance or a large volume at rest.     

Location of myocardial necrosis as an independent determinant of left ventricular performance: Analysis of 96 patients

This study determines whether the location of myocardial scarring has an effect independent of its size on left ventricular (LV) ejection fraction (EF) in patients with coronary artery disease. Two groups of patients were studied: Group I (n = 44) had resting thallium-201 perfusion defects involving the anterior wall or septum or both, and Group II (n = 52) had perfusion defects involving the inferior wall or posterior wall or both. The thallium images were divided into 5 segments in each of 3 projections, and the thallium score was determined from the number of abnormal segments and the degree of reduction of thallium uptake; the higher the score, the more severe the perfusion deficit.If the thallium score was <- 10, EF was 45 ± 14% (mean ± standard deviation) in Group I and 47 ±11% in Group II (p = not significant [NS]). If the thallium score was > 10, EF was 30 ± 12% in Group I and 32 ± 11% in Group II (NS). Similarly, EF was not significantly different between the 2 groups when the perfusion defects were assessed by the number of abnormal segments. In each group EF was significantly lower as the number of abnormal segments increased or as the thallium score was higher (p < 0.01). The results were unchanged when patients with resting ischemic defects or women were excluded.Thus, the location of myocardial scar itself is not important in determining LV function. However, the size of the scar is important in determining LVEF. Therefore, the fact that LVEF is lower in patients with anterior infarction than in those with inferior infarction must be related to the extent of muscle necrosis rather than to an anatomic factor.     

Cardiac performance in thyrotoxicosis: analysis of 10 untreated patients

This study attempts to define cardiac performance at rest and during exercise in patients with untreated thyrotoxicosis. We studied 7 women and 3 men, aged 23 to 59 years (40 +/- 10, mean +/- standard deviation [SD]) and compared the results with those obtained in 12 normal subjects. In patients with thyrotoxicosis, the rhythm was sinus and the only untoward symptom was palpitations; the resting electrocardiographic results were normal in 8 patients and showed left ventricular hypertrophy in 2 patients; the left ventricular ejection fraction and volumes (measured by radionuclide ventriculography) were normal at rest. During exercise, 1 patient had dyspnea and 7 had leg fatigue; 2 were asymptomatic. Also, 7 patients had greater than or equal to 5% increase in left ventricular ejection fraction, 2 had no change, and 1 had a decrease. In all 10 patients, the exercise ejection fraction was greater than or equal to 60%. All normal subjects had a greater than or equal to 5% increase in ejection fraction during exercise. There were no significant differences at rest between patients with thyrotoxicosis and normal subjects in blood pressure, ejection fraction, end-diastolic volume, stroke volume, end-systolic volume, or cardiac output, but the heart rate was significantly higher in patients with thyrotoxicosis (91 +/- 10 versus 80 +/- 12 beats/min, p less than 0.05). During exercise, there were no significant differences between patients with thyrotoxicosis and normal subjects in blood pressure, end-diastolic volume, stroke volume, end-systolic volume, or cardiac output. The exercise ejection fraction was significantly lower in patients with thyrotoxicosis than in normal subjects (68 +/- 10% versus 75 +/- 4%, p less than 0.05). Cardiac performance is normal at rest in patients with thyrotoxicosis, but during exercise abnormal left ventricular reserve occurs in some patients.     

Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery

In this double-blind parallel study, 99 patients with acute ventricular tachyarrhythmias after open-heart surgery were given either tocainide (50 patients) or lidocaine (49 patients) intravenously as 2 bolus injections 15 minutes apart, plus a fixed-rate infusion that started at the first bolus. If needed, a third bolus was administered and simultaneously the infusion rate was doubled. The boluses and initial infusion rate for tocainide treatment were, respectively, 250, 250 and 125 mg and 1.04 mg/min, and for lidocaine treatment, 100, 50 and 50 mg and 2.08 mg/min. When efficacy was defined as 80% or greater reduction in single ventricular premature complexes (VPCs) or complete abolition of ventricular couplets or ventricular tachycardia, no difference in efficacy between the 2 treatments was found by bedside electrocardiographic monitoring. By computer analysis of 24-hour taped electrocardiograms and a regression analysis of the proportion of patients responding favorably to treatment, it was estimated that an 80% or greater reduction of single VPCs occurred in 55% of patients during tocainide treatment and in 48% of patients during lidocaine treatment; abolition of couplets occurred in 74% and 68% of patients, respectively; and abolition of ventricular tachycardia in 87% and 73% of patients, respectively. These treatment-related differences were different (p less than 0.004). Adverse reactions occurred in 5 patients (10%) given tocainide (hypotension in 4; junctional rhythm in 1 patient; and nausea-vomiting in 1) and led to discontinuation of treatment in 3 patients.(ABSTRACT TRUNCATED AT 250 WORDS)     

Left ventricular function at rest and during exercise in congenital complete heart block: A radionuclide angiographic evaluation

This study evaluates intrinsic cardiac performance during upright exercise in patients with congenital complete heart block. Left ventricular ejection fraction and volume were measured at rest and peak upright exercise with radionuclide angiography in 5 patients aged 11 to 39 years with congenital complete heart block: 4 were in New York Heart Association class I and 1 was in class II. The resting cardiac output was maintained at a normal level by an increase in end-diastolic volume rather than by a decrease in end-systolic volume. The left ventricular ejection fraction was normal at rest in all patients, but an abnormal response to exercise was noted in 3 patients. There was no appreciable change in the end-diastolic volume during exercise. Thus, patients with congenital complete heart block utilize the Starling mechanism to maintain normal resting cardiac output, but the response to exercise is usually abnormal even in the absence of symptoms.     

Biventricular function in sickle-cell anemia: Radionuclide angiographic and thallium-201 scintigraphic evaluation

Left ventricular (LV) and right ventricular (RV) function were evaluated at rest and during exercise using radionuclide ventriculography in 10 patients, aged 19–53 years, with sickle-cell anemia (SCA). Seven patients were in New York Heart Association functional class I and 3 were in class II. The resting LV ejection fraction (EF) was normal in 9 patients and the resting RVEF was normal in 4. LV dilation and high cardiac output were observed in 6 patients at rest. The LVEF during exercise was normal in all 10 patients, whereas only 2 patients had normal RVEF at rest and during exercise. The LVEF was lower in patients with SCA at rest (54 ± 4 % versus 61 ± 6%, p < 0.001) and exercise (66 ± 4% versus 74 ± 6%, p < 0.001) than in 42 age-matched normal subjects. Rest thallium-201 images from 9 patients showed abnormal RV uptake in 8 and normal LV uptake in 8.Thus, in adult patients with SCA, LV function was normal during exercise in all patients and at rest in all but 1 patient. The LVEF, however, was lower than that in age-matched normal subjects. RV function was abnormal in most patients at rest and during exercise. RV thallium-201 uptake suggested pressure or volume overload (or both), most likely due to pulmonary vaso-occlusive complications of the disease.     

Tricuspid regurgitation: noninvasive techniques for determining causes and severity

Tricuspid regurgitation is often not apparent on physical examination and several methods are now available to aid in this difficult assessment. Cardiac catheterization using right ventriculography, previously considered the diagnostic standard, has several limitations. Currently available noninvasive tools such as M-mode and two-dimensional echocardiography (with or without contrast), Doppler techniques and even radionuclide cardiologic imaging have added significantly to the precise assessment of the presence and severity of tricuspid regurgitation. This review examines the comparative use and limitations of these various techniques.     

Significance of the upright T wave in precordial lead V1 in adults with coronary artery disease

To determine the prevalence and evaluate the significance of an upright T wave in precordial lead V1, the 12 lead electrocardiograms of 218 patients undergoing diagnostic catheterization for the evaluation of chest pain were reviewed. Of this total, 184 patients had severe coronary artery disease (greater than or equal to 75% luminal narrowing) and 34 patients had minimal or no coronary artery disease. An upright T wave in lead V1 (greater than or equal to 0.15 mV) was present in 3 subjects (9%) without coronary artery disease; in 19 (20%) of 96 patients with one vessel disease; in 14 (27%) of 51 patients with two vessel disease and in 13 (35%) of 37 patients with three vessel disease. Among the patients with one vessel disease, an upright T wave was more frequent in patients with left circumflex artery disease than in patients with left anterior descending or right coronary artery disease (probability [p] less than 0.001). Among patients with two vessel disease, an upright T wave was more frequent in patients with disease of the right coronary and left circumflex coronary arteries than in the remaining patients (p less than 0.005). It is concluded that an upright T wave in precordial lead V1 is common in patients with isolated left circumflex artery disease but is rare in those with isolated left anterior descending artery disease. Similarly, in patients with multivessel disease, an upright T wave is common when the left circumflex artery is diseased. This finding, along with other noninvasive tests, may prove useful in patient evaluation.     

Left ventricular function in patients with coronary heart disease in the presence or absence of angina pectoris during exercise radionuclide ventriculography

This study compares left ventricular (LV) performance during exercise in patients with angiographically documented coronary artery disease (CAD) based on the presence or absence of angina pectoris during the index exercise tests. The patients were divided into 2 groups: Group I included 31 patients who had angina pectoris during the test and Group II included 43 who did not. Multivessel CAD was present in 21 patients (68%) in Group I and 26 patients (60%) in Group II (difference not significant [NS]). There were no significant differences between the 2 groups in age, sex, history of diabetes mellitus, history of myocardial infarction and in the exercise duration, work load, heart rate and systolic blood pressure. Exercise-induced ST-segment depression was present in 48% of the patients in Group I and in 40% in Group II (NS). The mean LV ejection fraction at rest was 52 ± 12% in Group I and 50 ± 17% in Group II (NS). There were significant differences in the 2 groups in the change from rest to exercise in ejection fraction (?4.5 ± 7.6% in Group I vs 1 ± 9.4% in Group II, p < 0.01), end-systolic volume (29 ± 38 ml in Group I vs 9 ± 23 ml in Group II, p < 0.005), the change in systolic blood pressure-to-end-systolic volume ratio (?0.1 ± 0.5 mm Hg/ml in Group I vs 0.3 ± 1.1 mm Hg/ml in Group II, p < 0.05), and wall motion score (?0.4 ± 0.6 in Group I vs 0.09 ± 0.7 in Group II, p < 0.05).Thus, asymptomatic myocardial ischemia may occur in patients with extensive CAD and be associated with abnormal exercise LV function; however, patients with symptomatic CAD have worse exercise LV function than those with asymptomatic CAD.